Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Chi Chiu Mok. (2017) Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art. Expert Review of Clinical Immunology 13:7, pages 677-692.
Read now
Read now
Massimo Radin, Irene Cecchi, Karen Schreiber, Simone Baldovino, Daniela Rossi, Elisa Menegatti, Dario Roccatello & Savino Sciascia. (2017) Immunotherapies in phase II and III trials for the treatment of systemic lupus erythematosus. Expert Opinion on Orphan Drugs 5:1, pages 55-69.
Read now
Read now
Alba Velo-García, Eleana Ntatsaki & David Isenberg. (2016) The safety of pharmacological treatment options for lupus nephritis. Expert Opinion on Drug Safety 15:8, pages 1041-1054.
Read now
Read now
Chi Chiu Mok. (2014) Emerging biological therapies for systemic lupus erythematosus. Expert Opinion on Emerging Drugs 19:2, pages 303-322.
Read now
Read now
Chi Chiu Mok. (2014) Update on B-cell targeted therapies for systemic lupus erythematosus. Expert Opinion on Biological Therapy 14:6, pages 773-788.
Read now
Read now
Zahi Touma, Murray B Urowitz & Dafna D Gladman. (2013) Systemic lupus erythematosus: an update on current pharmacotherapy and future directions. Expert Opinion on Biological Therapy 13:5, pages 723-737.
Read now
Read now
Catherine Toong, Stephen Adelstein & Tri Giang Phan. (2011) Clearing the complexity: immune complexes and their treatment in lupus nephritis. International Journal of Nephrology and Renovascular Disease 4, pages 17-28.
Read now
Read now
Marion Haubitz. (2010) New and emerging treatment approaches to lupus. Biologics: Targets and Therapy 4, pages 263-271.
Read now
Read now
Articles from other publishers (18)
Arzu Soybilgic. (2022) Biologic Agents and Other Emerging Therapies for Childhood SLE. Pediatric Annals 51:2.
Crossref
Crossref
Georgia-Savina Moysidou & Dimitrios T. Boumpas. 2022. Systemic Lupus Erythematosus - Pathogenesis and Management [Working Title]. Systemic Lupus Erythematosus - Pathogenesis and Management [Working Title].
Javier Narváez. (2020) Lupus eritematoso sistémico 2020. Medicina Clínica 155:11, pages 494-501.
Crossref
Crossref
Javier Narváez. (2020) Lupus erythematosus 2020. Medicina Clínica (English Edition) 155:11, pages 494-501.
Crossref
Crossref
Dominik Samotij & Adam Reich. (2019) Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review. BioMed Research International 2019, pages 1-17.
Crossref
Crossref
Srinivasa Reddy Bonam, Fengjuan Wang & Sylviane Muller. (2018) Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option. Journal of Autoimmunity 94, pages 16-32.
Crossref
Crossref
Savino Sciascia, Massimo Radin, Dario Roccatello, Giovanni Sanna & Maria Laura Bertolaccini. (2018) Recent advances in the management of systemic lupus erythematosus. F1000Research 7, pages 970.
Crossref
Crossref
Judit Pozsgay, Zoltán Szekanecz & Gabriella Sármay. (2017) Antigen-specific immunotherapies in rheumatic diseases. Nature Reviews Rheumatology 13:9, pages 525-537.
Crossref
Crossref
Sonya VanPatten, Shan Sun, Mingzhu He, Kai Fan Cheng, Ahmad Altiti, Angelos Papatheodorou, Czeslawa Kowal, Venkatesh Jeganathan, James M. Crawford, Ona Bloom, Bruce T. Volpe, Christian Grant, Nathalie Meurice, Thomas R. Coleman, Betty Diamond & Yousef Al-Abed. (2016) Amending HIV Drugs: A Novel Small-Molecule Approach To Target Lupus Anti-DNA Antibodies. Journal of Medicinal Chemistry 59:19, pages 8859-8867.
Crossref
Crossref
Juan-Manuel Anaya, Carolina Duarte-Rey, Juan C. Sarmiento-Monroy, David Bardey, John Castiblanco & Adriana Rojas-Villarraga. (2016) Personalized medicine. Closing the gap between knowledge and clinical practice. Autoimmunity Reviews 15:8, pages 833-842.
Crossref
Crossref
Helena Hiemisch Lobo Borba, Andreas Funke, Astrid Wiens, Shirley Ramos da Rosa Utiyama, Cássio Marques Perlin & Roberto Pontarolo. (2016) Update on Biologic Therapies for Systemic Lupus Erythematosus. Current Rheumatology Reports 18:7.
Crossref
Crossref
Savino Sciascia, Eva Talavera-Garcia, Dario Roccatello, Simone Baldovino, Elisa Mengatti & Maria Jose Cuadrado. (2015) Upcoming biological therapies in systemic lupus erythematosus. International Immunopharmacology 27:2, pages 189-193.
Crossref
Crossref
Chia-Tse Weng, Ming-Fei Liu, Meng-Yu Weng, Nan-Yao Lee, Ming-Chang Wang, Wei-Chieh Lin, Chih-Ying Ou, Wu-Wei Lai, Shiang-Chin Hsu, Sheau-Chiou Chao, Ta-Jung Chung, Chung-Ta Lee, Chi-Chang Shieh, Jiu-Yao Wang & Chrong-Reen Wang. (2013) Pneumocystis jirovecii Pneumonia in Systemic Lupus Erythematosus From Southern Taiwan. Journal of Clinical Rheumatology 19:5, pages 252-258.
Crossref
Crossref
Grainne Murphy, Larissa Lisnevskaia & David Isenberg. (2013) Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment. The Lancet 382:9894, pages 809-818.
Crossref
Crossref
Preeta Kaur Chugh. (2012) Lupus: Novel therapies in clinical development. European Journal of Internal Medicine 23:3, pages 212-218.
Crossref
Crossref
Syuichi KOARADA, Satoko TASHIRO, Rie SUEMATSU, Hisako INOUE, Akihide OHTA & Yoshifumi TADA. (2012) BCMA and Autoantibody-producing RP105 B cells ; Possible new targets of B cell therapy in systemic lupus erythematosus自己抗体産生RP105陰性B細胞上に発現するB-cell maturation antigenは，全身性エリテマトーデスの治療標的となりうるか. Japanese Journal of Clinical Immunology 35:1, pages 38-45.
Crossref
Crossref
Guillermo J. Pons-Estel, Rosa Serrano, Miguel A. Plasín, Gerard Espinosa & Ricard Cervera. (2011) Epidemiology and management of refractory lupus nephritis. Autoimmunity Reviews 10:11, pages 655-663.
Crossref
Crossref
Kate Honnor. (2011) The changing face of lupus: evolution of diagnostics and treatments. Cambridge Medicine Journal:24.
Crossref
Crossref